drug

acoltremon

Marketedupdated 2mo ago

by $ALC ALCON INC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 31m ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

May 28, 2030

~3.9 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (5)

Dec 16, 2042formulationUS 11850221
Dec 16, 2042method-of-use (U-1900)US 12336971
Sep 8, 2031method-of-use (U-1900)US 10028920
Sep 8, 2031formulationUS 9095609
Sep 8, 2031method-of-use (U-1900)US 9433679

FDA exclusivities (1)

May 28, 2030NCENew Chemical Entity (5y)3.9y

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?